Scleroderma lung study (SLS): differences in the presentation and course of patients with limited versus diffuse systemic sclerosis
AUTOR(ES)
Clements, P J
FONTE
BMJ Group
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2095310Documentos Relacionados
- Pharmacodynamic effect of dipyridamole on thallium-201 myocardial perfusion in progressive systemic sclerosis with diffuse scleroderma.
- Lung Function in Patients with Systemic Sclerosis
- Antinuclear antibodies in patients with scleroderma (systemic sclerosis) and in their blood relatives and spouses.
- HLA class II genes associated with anticentromere antibody in Japanese patients with systemic sclerosis (scleroderma).
- Systemic sclerosis (scleroderma). Introduction.